Get the Stockscreener App
0.71
0.00%
0.00
After Hours:
.72
0.01
+1.41%
Invo Bioscience Inc stock is traded at $0.71, with a volume of 15,386.
It is up +0.00% in the last 24 hours and down -11.38% over the past month.
INVO Bioscience Inc operates a healthcare services fertility company. Assisted Reproductive Technology (ART) marketplace by making fertility care more accessible and inclusive to people. Its commercial strategy is focused on operating fertility-focused clinics, which includes the opening of dedicated INVO Centers offering the INVOcell and IVC procedure (with three centers in North America now operational) and the acquisition of US-based, profitable in vitro fertilization (IVF) clinics. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
See More
Previous Close:
$0.71
Open:
$0.7455
24h Volume:
15,386
Relative Volume:
0.09
Market Cap:
$2.77M
Revenue:
$1.92M
Net Income/Loss:
$-8.81M
P/E Ratio:
-0.0448
EPS:
-15.86
Net Cash Flow:
$-5.41M
1W Performance:
+2.39%
1M Performance:
-11.38%
6M Performance:
-37.17%
1Y Performance:
-10.15%
1-Day Range:
$0.69
$0.7455
1-Week Range:
$0.68
$0.7455
52-Week Range:
$0.50
$3.50
Invo Bioscience Inc Stock (INVO) Company Profile
Name
Invo Bioscience Inc
Sector
Industry
Phone
(978) 878-9505
Address
5582 BROADCAST COURT, SARASOTA
Invo Bioscience Inc Stock (INVO) Latest News
Research Analysts’ Weekly Ratings Updates for Innoviz Technologies (INVZ) - Defense World
Financial Health Report: Innoviva Inc (INVA)’s Ratios Tell a Tale - The Dwinnex
Interval Partners LP Has $2.52 Million Stock Holdings in Innoviz Technologies Ltd. (NASDAQ:INVZ) - Defense World
Seven Eight Capital LP Sells 17,969 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
Adversity is less terrifying than hope: Innoviz Technologies Ltd (INVZ) - SETE News
Analytical Lens: Exploring Iovance Biotherapeutics Inc (IOVA)’s Financial Story Through Ratios - The Dwinnex
Take off with Invivyd Inc (IVVD): Get ready for trading - SETE News
Inovio Pharmaceuticals Inc Inc. (INO) Price Performance: How to Use Technical Analysis to Make Trading Decisions - The InvestChronicle
Ratio Revelations: Inovio Pharmaceuticals Inc (INO)’s Financial Metrics in the Spotlight - The Dwinnex
Innoviva, Inc.'s (NASDAQ:INVA) Stock Is Going Strong: Have Financials A Role To Play? - Simply Wall St
(INO) Technical Pivots with Risk Controls - Stock Traders Daily
American Century Companies Inc. Purchases 361,797 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
InvenTrust Properties Corp. Announces Upsizing and Pricing of Common Stock Offering - StockTitan
InvenTrust Properties Corp. Announces Upsizing and Pricing of Common Stock Offering - Yahoo Finance
Innoviz Technologies (NASDAQ:INVZ) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
IOVA’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Innodata Target of Unusually Large Options Trading (NASDAQ:INOD) - Defense World
Incyte Insiders Sold US$4.8m Of Shares Suggesting Hesitancy - Simply Wall St
Itau Unibanco Holding S.A. Acquires New Position in Incyte Co. (NASDAQ:INCY) - Defense World
Pacer Advisors Inc. Buys 2,676,851 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
INVO Bioscience faces Nasdaq delisting over share price - Investing.com India
INVO Bioscience faces Nasdaq delisting over share price - Investing.com
INVO Bioscience faces Nasdaq delisting over share price By Investing.com - Investing.com Australia
MNC Capital Partners mantaining its $43 a share offer for Vista Outdoor - Arkansas Online
Inspire Investing LLC Sells 7,991 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
INVO Bioscience Risks Nasdaq Delisting Amid Stock Price Woes - TipRanks
31,047 Shares in Incyte Co. (NASDAQ:INCY) Purchased by XTX Topco Ltd - Defense World
Carolinas Wealth Consulting LLC Sells 101,115 Shares of Innoviz Technologies Ltd. (NASDAQ:INVZ) - Defense World
Meiji Yasuda Life Insurance Co Trims Position in Incyte Co. (NASDAQ:INCY) - Defense World
InnovAge (NASDAQ:INNV) Trading Up 4.2% - Defense World
INVO Bioscience extends merger agreement with NAYA - Investing.com India
INVO Bioscience extends merger agreement with NAYA - Investing.com
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 5.4% - Defense World
William Hoffman Sells 40,000 Shares of Inari Medical, Inc. (NASDAQ:NARI) Stock - Defense World
Incyte stock downgraded amid looming patent cliff concerns By Investing.com - Investing.com Canada
Insider Selling: InnovAge Holding Corp. (NASDAQ:INNV) Insider Sells 4,372 Shares of Stock - Defense World
InnovAge holding corp. executive sells over $70k in stock By Investing.com - Investing.com UK
Inari Medical director sells $1.83M in common stock - TipRanks
Inari medical director Hoffman sells over $1.8m in company stock - Investing.com UK
Innoviz Technologies Ltd (INVZ) looking to reclaim success with recent performance - SETE News
Incyte DowngradedAnalyst Notes Intense Competition, Particularly In Larger Markets - Yahoo Finance
Daiwa Securities Group Inc. Buys 7,781 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Incyte (NASDAQ:INCY) Stock Price Down 1.9% - MarketBeat
Victory Capital Management Inc. Buys 52,523 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Incyte (NASDAQ:INCY) Receives Market Perform Rating from JMP Securities - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Rhumbline Advisers - Defense World
INVO Bioscience (NASDAQ:INVO) Stock Price Down 1.7% - Defense World
For Iovance Biotherapeutics Inc [IOVA], Analyst sees a drop to $10. What next? - The DBT News
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
INOVIO to Present at Upcoming Scientific Conference - Marketscreener.com
INOVIO to Present at Upcoming Scientific Conference - StockTitan
Invo Bioscience Inc Stock (INVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):